Find comprehensive information on Hodgkin's Lymphoma diagnosis, including clinical documentation requirements, medical coding guidelines, and healthcare resources. Learn about Hodgkin's Lymphoma staging, Ann Arbor classification, ICD-10 codes, SNOMED CT codes, pathology reports, diagnostic criteria, and treatment options. This resource provides valuable information for healthcare professionals, medical coders, and patients seeking to understand Hodgkin's Lymphoma diagnosis and management.
Also known as
Hodgkin lymphoma
Malignant neoplasm of lymphoid tissue characterized by Reed-Sternberg cells.
Secondary and unspecified malignant neoplasm of lymph nodes
Spread of Hodgkin lymphoma or other cancers to lymph nodes, primary site unknown.
Other specified types of non-Hodgkin lymphoma
Includes rare lymphomas that are not Hodgkin lymphoma or common non-Hodgkin types.
Personal history of Hodgkin lymphoma
Indicates a patient has been previously treated for Hodgkin lymphoma and is now in remission or cured.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is it Hodgkin lymphoma?
Inaccurate Ann Arbor staging impacts code selection (e.g., C81.7X) and treatment planning, affecting reimbursement and quality metrics. CDI crucial for accurate documentation.
Miscoding of subtypes like nodular sclerosis (C81.0X) or mixed cellularity (C81.2X) leads to incorrect DRG assignment and skewed registry data, impacting resource allocation.
Failure to distinguish active disease (C81.YX) from remission (Z85.61) or history of (Z85.41) affects coding accuracy, impacting surveillance and treatment planning. Requires precise clinical documentation.
Patient presents with complaints suggestive of Hodgkin's Lymphoma. Symptoms include painless lymphadenopathy, primarily in the cervical or supraclavicular region, accompanied by fatigue, night sweats, unexplained weight loss, and intermittent fever. Physical examination reveals palpable, firm, non-tender lymph nodes. Complete blood count may show anemia, leukocytosis, or lymphopenia. Excisional lymph node biopsy performed for histopathological evaluation reveals the presence of Reed-Sternberg cells, confirming the diagnosis of Hodgkin's Lymphoma. Immunohistochemistry staining and flow cytometry aid in subtyping the lymphoma. Staging workup, including PET-CT scan and bone marrow biopsy, is performed to determine the extent of the disease. Ann Arbor staging classification will be utilized. Differential diagnosis includes non-Hodgkin's lymphoma, infectious mononucleosis, and other lymphoproliferative disorders. Treatment plan will be determined based on the stage and subtype of Hodgkin's Lymphoma and may include chemotherapy regimens such as ABVD, BEACOPP, or Stanford V, radiation therapy, or targeted therapy. Patient education regarding treatment options, potential side effects, and prognosis will be provided. Follow-up appointments will be scheduled for monitoring treatment response and managing any complications. ICD-10 code C81. Medical billing codes will reflect the specific procedures performed and therapies administered.